Gilead nears deal to buy Immunomedics for more than $20 bn: WSJ report
(Reuters) – Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more
Read more(Reuters) – Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more
Read moreAmid a raging controversy over Facebook’s alleged political bias and interference in India’s democratic process, the social
Read moreThe Trinamool Congress has written to Facebook CEO Mark Zuckerberg raising the issue of alleged bias of the social media
Read more